肝硬化患者止凝血功能检测的临床意义  

Clinical Significance of Determination of Hemostasis and Blood Coagulation in the Patients with Hepatic Cirrhosis

作　　者：佃雪辉 廖若男[2] 陈晓琴[1] 杨爱云[2] 周力[1] 闵忠 

机构地区：[1]贵阳医学院内科学教研室,贵阳550004 [2]贵阳医学院临床血液学检验教研室

出　　处：《贵阳医学院学报》1996年第1期9-13,共5页Journal of Guiyang Medical College

摘　　要：对42例不同病期的肝硬化患者进行9项止凝血功能的检测。结果显示因子ⅦR:Ag 在肝功能代偿期中已显著增高,并随病情的进展而发生相应的变化,故ⅧR:Ag 的检测可作为早期肝功能损害及预后判断的指标。在 C 级组的病人中,PT 及 TT 均较 A 级组明显延长(P<0.01或 P<0.05),提示二者的检测检结果与病变的损害程度密切相关,可作为预后断判的指标。Nine tests for hemostasis and blood coagulation were determined in 48 patients with various grade of hepatic cirrhosis.The results showed that factor ⅧR:Ag was significantly increased in patients with A grade of hepatic cirrhosis than in normals and correlated with the disease process.We suggest that the detection of factor ⅧR:Ag has early diagnostic and prognostic value.In the patients of C grade PT and TT were prolonged significantly than that of A grade(P<0.01 or P<0.05).The changes of PT and TT may reflect the degree of damage in liver function and may be an useful indi- cator of prognosis.

关 键 词：肝硬变 凝血酶原时间 凝血酶时间 

分 类 号：R575.204[医药卫生—消化系统]